Does TOFACITINIB Cause Polyarthritis? 308 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 308 reports of Polyarthritis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.2% of all adverse event reports for TOFACITINIB.
308
Reports of Polyarthritis with TOFACITINIB
0.2%
of all TOFACITINIB reports
14
Deaths
168
Hospitalizations
How Dangerous Is Polyarthritis From TOFACITINIB?
Of the 308 reports, 14 (4.5%) resulted in death, 168 (54.5%) required hospitalization, and 54 (17.5%) were considered life-threatening.
Is Polyarthritis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 308 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Polyarthritis?
METHOTREXATE (987)
ADALIMUMAB (864)
INFLIXIMAB (670)
ETANERCEPT (642)
TOCILIZUMAB (575)
HYDROXYCHLOROQUINE (562)
SULFASALAZINE (548)
ABATACEPT (546)
PREDNISONE (535)
NAPROXEN (442)
Which TOFACITINIB Alternatives Have Lower Polyarthritis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN